Bank of America’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1
| Closed | -$23 | – | 7093 |
|
|
2023
Q2 | $23 | Sell |
1
-681
| -100% | -$15.7K | ﹤0.01% | 6615 |
|
|
2023
Q1 | $8.25K | Sell |
682
-2
| -0.3% | -$24 | ﹤0.01% | 6145 |
|
|
2022
Q4 | $3.11K | Sell |
684
-12
| -2% | -$55 | ﹤0.01% | 6324 |
|
|
2022
Q3 | $5K | Sell |
696
-52
| -7% | -$374 | ﹤0.01% | 6543 |
|
|
2022
Q2 | $8K | Sell |
748
-747
| -50% | -$7.99K | ﹤0.01% | 6654 |
|
|
2022
Q1 | $29K | Sell |
1,495
-527
| -26% | -$10.2K | ﹤0.01% | 6586 |
|
|
2021
Q4 | $72K | Buy |
2,022
+409
| +25% | +$14.6K | ﹤0.01% | 6201 |
|
|
2021
Q3 | $118K | Buy |
1,613
+629
| +64% | +$46K | ﹤0.01% | 5772 |
|
|
2021
Q2 | $137K | Buy |
984
+519
| +112% | +$72.3K | ﹤0.01% | 5552 |
|
|
2021
Q1 | $135K | Buy |
+465
| New | +$135K | ﹤0.01% | 5600 |
|